|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pharmacology, University of South Alabama, College of Medicine, Mobile, Alabama, United States
2 Chemical Engineering, University of California at Berkeley, Berkeley, California, United States
3 Biomedical Sciences, University of South Alabama, Mobile, Alabama, United States
4 Cell Biology and Neurosciences, University of South Alabama, College of Medicine, Mobile, Alabama, United States
* To whom correspondence should be addressed. E-mail: sschaffe{at}jaguar1.usouthal.edu.
Recently it has become apparent that mtDNA damage can rapidly initiate apoptosis independent of mutations, although the mechanism involved remains unclear. To elucidate this mechanism, angiotensin II-mediated apoptosis was studied in cells that were transduced with a lentiviral vector to overexpress the DNA repair enzyme, 8-oxoguanine glycosylase, or treated with inhibitors known to block angiotensin II-induced mtDNA damage. Cells exhibiting angiotensin II-induced mtDNA damage showed two phases of superoxide generation, the first derived from NAD(P)H oxidase and the second of mitochondrial origin, while cells prevented from experiencing mtDNA damage importantly exhibited only the first phase. Futhermore, cells with mtDNA damage demonstrated impairments in mitochondrial protein expression, cellular respiration, and complex 1 activity prior to the onset of the second phase of oxidation. Following the second phase, the mitochondrial membrane potential collapsed, cytochrome c was released, and the cells underwent apoptosis, all of which were prevented by disrupting mtDNA damage. Collectively, these data reveal a novel mechanism of apoptosis that is initiated when mtDNA damage triggers mitochondrial superoxide generation and ultimately the activation of the mitochondrial permeability transition. This novel mechanism may play an important pathological role.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |